Palliative treatment of pancreatic cancer

被引:19
作者
Von Wichert, Goetz [1 ]
Seufferlein, Thomas [1 ]
Adler, Guido [1 ]
机构
[1] Univ Ulm, Dept Internal Med 1, D-89081 Ulm, Germany
关键词
chemotherapy; gemcitabine; pancreatic cancer; targeted therapies;
D O I
10.1111/j.1443-9573.2007.00314.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Despite numerous diagnostic possibilities the early diagnosis of pancreatic cancer is still an exemption. Only 10-15% of patients are diagnosed at a stage where the tumor is resectable. Thus, most patients are treated with a palliative intention at first diagnosis. Palliative treatment comprises different therapeutic modalities involving radiochernotherapy and conventional chemotherapy. Chemotherapy, in particular, has been challenged by several new concepts involving combination regimens and the addition of targeted therapies to conventional therapeutic regimens. This review offers a critical presentation of current concepts in the palliative treatment of pancreatic cancer, discussing the problems of each and pointing to the development of new therapeutic strategies.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 36 条
[1]   Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer [J].
Abou-Alfa, Ghassan K. ;
Letourneau, Richard ;
Harker, Graydon ;
Modiano, Manuel ;
Hurwitz, Herbert ;
Tchekmedyian, Nerses Simon ;
Feit, Kevie ;
Ackerman, Judie ;
De Jager, Robert L. ;
Eckhardt, S. Gail ;
O'Reilly, Eileen M. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) :4441-4447
[2]  
[Anonymous], [No title captured]
[3]  
[Anonymous], J CLIN ONCOL
[4]  
*ARB BEV KREBSR DE, 2002, HAUF TRENDS, P32
[5]   Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297 [J].
Berlin, JD ;
Catalano, P ;
Thomas, JP ;
Kugler, JW ;
Haller, DG ;
Benson, AB .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) :3270-3275
[6]  
Boeck S, 2006, J CLIN ONCOL, V24, p208S
[7]   Marimastat as first-line therapy for patients with unresectable pancreatic cancer: A randomized trial [J].
Bramhall, SR ;
Rosemurgy, A ;
Brown, PD ;
Bowry, C ;
Buckels, JAC .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (15) :3447-3455
[8]   Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial [J].
Burris, HA ;
Moore, MJ ;
Andersen, J ;
Green, MR ;
Rothenberg, ML ;
Madiano, MR ;
Cripps, MC ;
Portenoy, RK ;
Storniolo, AM ;
Tarassoff, P ;
Nelson, R ;
Dorr, FA ;
Stephens, CD ;
VanHoff, DD .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2403-2413
[9]  
Chauffert B, 2006, J CLIN ONCOL, V24, p180S
[10]  
CUNNINGHAM D, 2005, EUROPEAN J CANC S, V3